文献速递临床生化质量管理与危急值

多点内标校准实现血清甲氨蝶呤质谱检测的随机访问

Calibrating from Within: Multipoint Internal Calibration of a Quantitative Mass Spectrometric Assay of Serum Methotrexate.
PubMed 文献 · Clin Chem · 2020-01-01

研究开发多点内标校准(MPIC)法,用4种13C标记甲氨蝶呤(0.026-10.3 µM)作为每个样本的内标曲线,消除批量校准需求。多中心验证显示回收率93%-102%,LLOQ为0.017 µM,20天总变异11.5%CV,线性r2>0.995,与常规LC-MS/MS和免疫法结果可比。

要点

  • MPIC法用同位素内标曲线实现随机访问LC-MS/MS检测,无需批处理校准。
  • 回收率93%-102%,LLOQ 0.017 µM,20天总变异11.5%CV,线性良好。
  • 与常规LC-MS/MS和免疫法结果可比,MTX>0.4 µM时偏差很少超过20%。

核心结论

  • MPIC法经多中心概念验证,是实现随机访问LC-MS/MS分析的重要进展,可能改变质谱在临床实验室的应用模式。

研究设计与样本

  • 多中心概念验证研究,一个中心进行全面验证(干扰、基质效应、LLOQ、20天精密度),三个中心评估精密度和线性。

主要发现

  • 加标回收率为93%-102%,LLOQ验证为0.017 µM。
  • 20天实验总变异为11.5%CV;各中心5天变异研究总不精密度为3.4至16.8%CV。
  • 校准范围内线性验证良好(r2 > 0.995,斜率=0.996-1.01)。
  • 各实验室检测40份样本,中位室间不精密度为6.55%CV。
  • MPIC定量与常规LC-MS/MS和免疫法可比(r2=0.96-0.98,斜率=1.04-1.06);Bland-Altman分析显示MTX浓度>0.4 µM时偏差很少超过20%。

临床怎么用

  • MPIC法可用于血清甲氨蝶呤定量,支持随机访问检测,减少批量校准需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical LC-MS/MS assays traditionally require that samples be run in batches with calibration curves in each batch. This approach is inefficient and presents a barrier to random access analysis. We developed an alternative approach called multipoint internal calibration (MPIC) that eliminated the need for batch-mode analysis. METHODS: The new approach used 4 variants of 13C-labeled methotrexate (0.026-10.3 µM) as an internal calibration curve within each sample. One site carried out a comprehensive validation, which included an evaluation of interferences and matrix effects, lower limit of quantification (LLOQ), and 20-day precision. Three sites evaluated assay precision and linearity. MPIC was also compared with traditional LC-MS/MS and an immunoassay. RESULTS: Recovery of spiked analyte was 93%-102%. The LLOQ was validated to be 0.017 µM. Total variability, determined in a 20-day experiment, was 11.5%CV. In a 5-day variability study performed at each site, total imprecision was 3.4 to 16.8%CV. Linearity was validated throughout the calibrator range (r2 > 0.995, slopes = 0.996-1.01). In comparing 40 samples run in each laboratory, the median interlaboratory imprecision was 6.55%CV. MPIC quantification was comparable to both traditional LC-MS/MS and immunoassay (r2 = 0.96-0.98, slopes = 1.04-1.06). Bland-Altman analysis of all comparisons showed biases rarely exceeding 20% when MTX concentrations were >0.4 µM. CONCLUSION: The MPIC method for serum methotrexate quantification was validated in a multisite proof-of-concept study and represents a big step toward random-access LC-MS/MS analysis, which could change the paradigm of mass spectrometry in the clinical laboratory.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Hoffman MA, Schmeling M, Dahlin JL, et al. Calibrating from Within: Multipoint Internal Calibration of a Quantitative Mass Spectrometric Assay of Serum Methotrexate. Clin Chem. 2020. PMID: 32057077. doi:10.1093/clinchem/hvaa003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。